SCHEMBL25709644

SCHEMBL25709644

CC1(C)OB(c2ccc(-c3nc(-c4ccc(C#N)cc4)nc(-c4cccc5ccccc45)n3)cc2C#N)OC1(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.36
XDH P47989 1/20 0.36
FNTA P49354 4/20 0.35
FNTB P49356 4/20 0.35
PGGT1B P53609 3/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
CYP1A2 P05177 2/20 0.35
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
KMT2A Q03164 2/20 0.35
CLK4 Q9HAZ1 2/20 0.35
LMNA P02545 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
TSHR P16473 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.33
MAPK1 P28482 1/20 0.33
LPL P06858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30616366 0.83 LPL (0.43) MEN1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL26131069 0.83 LPL (0.43) MEN1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL27277957 0.78 XDH (0.33) MCL1XDHALDH1A1TSHRHSD17B10
SCHEMBL31643719 0.77 LPL (0.37) MEN1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL22115508 0.77 ABCG2 (0.45) MCL1MEN1ALDH1A1CYP1A2CYP3A4
SCHEMBL23075563 0.76 LIPG (0.53) ALDH1A1LMNATSHRHSD17B10MAPK1
SCHEMBL31643430 0.76 LPL (0.39) ABCG2LPLLIPG
SCHEMBL31643748 0.76 LPL (0.39) MEN1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL31643730 0.75 LPL (0.37) MEN1ALDH1A1CYP1A2CYP3A4CYP2C19
SCHEMBL22639360 0.75 LIPG (0.55) ALDH1A1LMNATSHRHSD17B10MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746093-B2 Nitrogen-containing compound, electronic element, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-05 US disclosed
US-11746093-B2 Nitrogen-containing compound, electronic element, and electronic device SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-09-05 US disclosed
US-20230192627-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230192627-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11746093-B2 Nitrogen-containing compound, electronic element, and electronic device SLC43A1, SLC7A5, L1CAM MCL1 4511/4885XDH 1111/4885FNTA 2174/4885
US-20230192627-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE SLC43A1, SLC7A5, L1CAM MCL1 4511/4885XDH 1111/4885FNTA 2174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.